Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Expand Canadian Rx Import Program | The act states that the department of health care policy and financing (department) may expand the Canadian prescription drug importation program (program) to allow a manufacturer, wholesale distributor, or pharmacy from a nation other than Canada to export prescription drugs into the state under the program if certain conditions are met. If, upon the satisfaction of these conditions, the department decides to expand the program, the executive director of the department shall notify the president of the senate, the speaker of the house of representatives, and specified legislative committees of the department's intent to do so.(Note: This summary applies to this bill as enacted.) | us/states/co | Colorado General Assembly | 2021A | SB 21-123 | Colorado SB 21-123 (2021A) |
|
enacted |
|
8 | 14 | 3 | 2021-02-25T07:00:00+00:00 | 2021-04-26T06:00:00+00:00 | openstates | ocd-bill/262e46de-6092-49fd-9963-3b74aa86a53b | http://leg.colorado.gov/bills/sb21-123 | bff1585bb712d9fd47902caecb06977d860eb5f204d99539745aa3fa4a60afe7 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Colorado SB 21-123 (2021A) — Expand Canadian Rx Import Program
The act states that the department of health care policy and financing (department) may expand the Canadian prescription drug importation program (program) to allow a manufacturer, wholesale distributor, or pharmacy from a nation other than Canada to export prescription drugs into the state under the program if certain conditions are met. If, upon the satisfaction of these conditions, the department decides to expand the program, the executive director of the department shall notify the president of the senate, the speaker of the house of representatives, and specified legislative committees of the department's intent to do so.(Note: This summary applies to this bill as enacted.)
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Committee Amendment (committee substitute) — source
- Engrossed (03/11/2021) (committee substitute) — source
- Final Act (04/16/2021) (committee substitute) — source
- Introduced (02/25/2021) (committee substitute) — source
- Reengrossed (03/12/2021) (committee substitute) — source
- Rerevised (04/13/2021) (committee substitute) — source
- Revised (04/12/2021) (committee substitute) — source
- Signed Act (04/26/2021) (committee substitute) — source
Votes
- BILL — 50–15 (pass) · lower
- BILL — 27–6 (pass) · upper
- BILL — 28–6 (pass) · upper
Sponsors
- Don Coram — primary (person)
- Joann Ginal — primary (person)
- Karen McCormick — primary (person)
- Mike Lynch — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-04-26T06:00:00+00:00 Governor Signed
executive-signature - 2021-04-16T06:00:00+00:00 Sent to the Governor
executive-receipt - 2021-04-16T06:00:00+00:00 Signed by the Speaker of the House
- 2021-04-16T06:00:00+00:00 Signed by the President of the Senate
- 2021-04-13T06:00:00+00:00 House Third Reading Passed - No Amendments
passage, reading-3 - 2021-04-12T06:00:00+00:00 House Second Reading Passed - No Amendments
reading-2 - 2021-04-07T06:00:00+00:00 House Committee on Health & Insurance Refer Unamended to House Committee of the Whole
committee-passage, referral-committee - 2021-03-17T06:00:00+00:00 Introduced In House - Assigned to Health & Insurance
introduction - 2021-03-12T07:00:00+00:00 Senate Third Reading Passed - No Amendments
passage, reading-3 - 2021-03-12T07:00:00+00:00 Senate Third Reading Reconsidered - No Amendments
- 2021-03-12T07:00:00+00:00 Senate Third Reading Passed - No Amendments
passage, reading-3 - 2021-03-11T07:00:00+00:00 Senate Second Reading Passed - No Amendments
reading-2 - 2021-03-08T07:00:00+00:00 Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
committee-passage, referral-committee - 2021-02-25T07:00:00+00:00 Introduced In Senate - Assigned to Health & Human Services
introduction
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/262e46de-6092-49fd-9963-3b74aa86a53b. Confidence: reported (aggregated from official Colorado legislature records).